• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Codagenix, Inc. logo
Menu
  • Approach
  • Pipeline
  • Team
  • Careers
  • News
  • Publications
  • Contact
Back to news
PR Newswire
2020 / Press Releases

Codagenix and Serum Institute of India Announce Commencement of First-in-Human Trial of COVI-VAC, A Single Dose, Intranasal Live Attenuated Vaccine for COVID-19 

Codagenix, Inc. logo
  • Approach
  • Pipeline
  • Team
  • Careers
  • News
  • Publications

Get in touch with us.

CONTACT US
Privacy Policy Terms & Conditions
© Codagenix 2022. All Rights Reserved.
Back to top